Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 350

1.

The molecular adjuvant mC3d enhances the immunogenicity of FimA from type I fimbriae of Salmonella enterica serovar Enteritidis.

Musa HH, Zhang WJ, Lv J, Duan XL, Yang Y, Zhu CH, Li HF, Chen KW, Meng X, Zhu GQ.

J Microbiol Immunol Infect. 2014 Feb;47(1):57-62. doi: 10.1016/j.jmii.2012.11.004. Epub 2013 Jan 24.

2.

Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.

Tennant SM, Schmidlein P, Simon R, Pasetti MF, Galen JE, Levine MM.

Infect Immun. 2015 Dec;83(12):4504-12. doi: 10.1128/IAI.00924-15. Epub 2015 Sep 8.

3.

Immunogenicity of Salmonella enterica serovar Enteritidis virulence protein, InvH, and cross-reactivity of its antisera with Salmonella strains.

Dehghani B, Rasooli I, Gargari SL, Nadooshan MR, Owlia P, Nazarian S.

Microbiol Res. 2013 Feb 22;168(2):84-90. doi: 10.1016/j.micres.2012.09.002. Epub 2012 Nov 6.

4.
7.

Reduction of Salmonella enteritidis number after infections by immunization of liposome-associated recombinant SefA.

Pang Y, Zhang Y, Wang H, Jin J, Piao J, Piao J, Liu Q, Li W.

Avian Dis. 2013 Sep;57(3):627-33.

PMID:
24283128
9.

Immune response to liposome-associated recombinant SEF21 following oral immunization in chickens.

Pang Y, Wang H, Li Z, Piao J, Piao J, Chi Y, Jin J, Liu Q, Li W.

Avian Dis. 2012 Jun;56(2):347-53.

PMID:
22856192
10.
12.
13.

Protective immunity of biodegradable nanoparticle-based vaccine against an experimental challenge with Salmonella Enteritidis in mice.

Ochoa J, Irache JM, Tamayo I, Walz A, DelVecchio VG, Gamazo C.

Vaccine. 2007 May 30;25(22):4410-9. Epub 2007 Apr 2.

PMID:
17434651
15.

Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination.

Strindelius L, Degling Wikingsson L, Sjöholm I.

Infect Immun. 2002 Mar;70(3):1434-42.

16.

Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.

Simon R, Tennant SM, Wang JY, Schmidlein PJ, Lees A, Ernst RK, Pasetti MF, Galen JE, Levine MM.

Infect Immun. 2011 Oct;79(10):4240-9. doi: 10.1128/IAI.05484-11. Epub 2011 Aug 1.

17.
18.

Host and bacterial factors affecting induction of immune responses to flagellin expressed by attenuated Salmonella vaccine strains.

Sbrogio-Almeida ME, Mosca T, Massis LM, Abrahamsohn IA, Ferreira LC.

Infect Immun. 2004 May;72(5):2546-55.

19.

Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus.

Zhang D, Xia Q, Wu J, Liu D, Wang X, Niu Z.

Vaccine. 2011 Jan 17;29(4):629-35. doi: 10.1016/j.vaccine.2010.11.046. Epub 2010 Dec 4.

PMID:
21134449
20.

Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.

Kim TG, Huy NX, Kim MY, Jeong DK, Jang YS, Yang MS, Langridge WH, Lee JY.

Mol Biotechnol. 2009 Feb;41(2):157-64. doi: 10.1007/s12033-008-9102-3. Epub 2008 Sep 20.

PMID:
18807220

Supplemental Content

Support Center